Neovascularisation in asthma: Altered angiogenic potential of ASM cells from asthmatic patients

L. Keglowich, M. Roth, M. Philippova, T. J. Resink, M. Tamm, P. Borger (Basel, Switzerland)

Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Session: Molecular biology of pro- and anti-inflammatory responses in the lung
Session type: Thematic Poster Session
Number: 3710
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Keglowich, M. Roth, M. Philippova, T. J. Resink, M. Tamm, P. Borger (Basel, Switzerland). Neovascularisation in asthma: Altered angiogenic potential of ASM cells from asthmatic patients. Eur Respir J 2012; 40: Suppl. 56, 3710

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Neo-vascularisation in asthma: Altered angiogenic potential of ASM cells from asthmatic patients
Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology
Year: 2011

Decreased hyaluronan in airway smooth muscle cells of asthma and COPD patients
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD
Year: 2009


Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1ß treatment: a novel role for CCL20 in chronic mucus hypersecretion
Source: Eur Respir J, 52 (2) 1800310; 10.1183/13993003.00310-2018
Year: 2018



Corticosteroids and beta2-agonists regulate pathologic homeostasis of hyaluronic acid in human airway smooth muscle cells from patients with asthma and COPD. Therapeutic relevance
Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs
Year: 2010


Are asthma and COPD translation control diseases? Translational defect of cell cycle regulators C/EBP-α and -δ in airway smooth muscle cells (ASMC) of patients with asthma and COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 20s
Year: 2005

Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013

Increased numbers of alveolar mast cells with an altered phenotype are linked to peripheral airway remodelling in patients with allergic asthma
Source: Annual Congress 2012 - Mechanisms of asthma
Year: 2012

LSC Abstract – Defect in the translational control of cytokines leading to hyperresponsive bronchial epithelial cells in asthmatics
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016



In vivo allergen-activated inflammatory eosinophils reduced airway smooth muscle cells apoptosis in allergic asthma patients
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021


Disease specific effects of adrenomedullin in COPD and asthma derived human bronchial epithelial cells
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015

Cytokine regulation of the chronicle inflammation of bronchial asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 590s
Year: 2005

Small airway fibroblasts from COPD patients are senescent and pro-fibrotic
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018



Inhaled budesonide induces corticosteroid-dependent gene expression in asthmatics: Validation in primary epithelial and airways smooth muscle cells
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011


LSC Abstract – Eosinophils enhance WNT-5a and TGF-β1 genes expression in airway smooth muscle cells and promote their proliferation in asthma
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016

Relative corticosteroid insensitivity in human airway smooth muscle cells from severe asthma patients in terms of transrepression not transactivation
Source: Annual Congress 2010 - Airway smooth muscle cells
Year: 2010


Different prostanoid phenotypes in lung fibroblasts from patients with asthma and COPD
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009


IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status?
Source: International Congress 2017 – Monitoring asthma control
Year: 2017

Corticosteroid insensitivity in airway smooth muscle cells of severe asthma and COPD: Modulation by IFN-γ
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012


EGR-1 as a potential biomarker in asthma and proinflammatory responses in airway epithelium
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021